Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 3.88B |
| Enterprise Value | 3.69B |
| P/E Ratio | -28.63 |
| PEG Ratio | 0.22 |
| Price/Sales Ratio | 4.44 |
| Price/Book Ratio | 0.93 |
| Enterprise/Revenue | 4.41 |
| Enterprise/EBITDA | -1,011.27 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.16 |
| Operating Margin | -0.16 |
| Return On Assets | -0.03 |
| Return On Equity | -0.03 |
| Revenue | 563.14M |
| Revenue/Share | 1.96 |
| Gross Profit | 574.88M |
| EBITDA | 203.16M |
| Net Income | 143.72M |
| Diluted EPS | 0.86 |
| Total Cash | 351.48M |
| Total Cash/Share | 2.11 |
| Total Debt | 179.02M |
| Total Debt/Equity | 0.12 |
| Current Ratio | 3.85 |
| Book Value Per Share | 9.3 |
| 52-Week Change | -68.62 |
| 52-Week High | 27.4 |
| 52-Week Low | 6.91 |
| Moving Average 50 Days | 8.81 |
| Moving Average 200 Days | 15.75 |
| Average Volume | 3.09M |
| Shares Outstanding | 168.31M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.04 |
| Last Split Factor | 7:5 |
| Last Split Date | July 18, 2023 |